Extramural Research
![Man using virtual reality headset](https://public4.pagefreezer.com:443/content/FDA/10-09-2022T09:11/https://www.fda.gov/files/styles/main_image_medium/public/iStock-1155257412.jpg?itok=Lf2ucK2K)
The Office of Minority Health and Health Equity (OMHHE) Research and Collaboration Program works with external partners to support research studies about minority health and health disparities. Research under this program provides insight into the scientific basis for individual therapies. Studies also provide future directions for research and aid regulatory decision-making.
Sign up to receive OMHHE Enhance Equity Initiative Funding Opportunities updates and for information on available funding opportunities.
Project | Awarded To | Fiscal Year | Funding Mechanism | Status |
---|---|---|---|---|
Co-creation of digital tools to enhance young adult minority participation in COVID-19 trials | California State University, Fullerton | 2022 | RFA | On Going |
Hispanic, black and pacific islandeR perspectives on COVID-19 oUtreach Strategies and patient centered outcomes (HeAR US) | Queens Medical Center | 2022 | RFA | On Going |
COMmunity Mistrust and Institutional Trustworthiness to advance health EQuity research (COMMIT-EQ) | University of Maryland, Baltimore | 2022 | RFA | On Going |
Center for Advancing COVID-19 Health Equity Research | Florida Agricultural and Mechanical University | 2022 | RFA | On Going |
Utilizing the Pharmacy Advances Clinical Trials (PACT) Network to Achieve Diversity in COVID Clinical Trials: A Strategic Framework | Texas A&M University Health Science Center | 2022 | RFA | On Going |
Bridging Gaps: Recruiting African American and Asian American Participants for COVID-19 Clinical Trials and Creating Culturally Competent Messages | Howard University | 2021 | BAA | On Going |
Improving clinical trial diversity and participation among people living with Chronic Hepatitis B | Hepatitis B Foundation | 2021 | BAA | On Going |
Integrating patient and consumer-generated discursive data to inform and enhance FDA One Health Initiative communication strategies | University of Maryland | 2021 | CERSI | On Going |
Exploring the use of Real-World Data to Generate Real-World Evidence to support COVID-19 treatment outcomes among racial and ethnic minority groups | US Department of Veterans Affairs | 2021 | IAA | On Going |
Using Big Data, Machine Learning, and Infoveillance Approaches to Detect and Characterize Adoptions and Adherence to PrEP Therapy Among Minority Populations | S-3 Research | 2021 | BAA | On Going |
Skin Lightening Products: Understanding Consumer Perspectives and Effective Educational Messages | Reagan-Udall Foundation | 2021 | Cooperative Agreement | On Going |
Understanding Barriers to Hepatitis B Clinical Trials | Hepatitis B Foundation | 2020 | RCA | On Going |
Leveraging Community Engagement and Electronic Health Record Strategies to Promote Diverse Participation in COVID-19 Clinical Trials | Yale University | 2020 | BAA | On Going |
Beyond Clinical Trials: Investments in Real world Evidence and Artificial intelligence for Studying the Safety of DOACs among Veterans | US Department of Veterans Affairs | 2020 | IAA | On Going |
Characterizing Population-Specific Clinical Asthma Profiles | University of California, San Francisco-Stanford University | 2020 | CERSI | On Going |
Usability Testing of Virtual Reality for Pain Management Among Diverse Patients | University of California, San Francisco-Stanford University | 2020 | CERSI | On Going |
Social Listening for Patient Perspectives on Chronic Pain | Inspire | 2019 |
BAA |
Complete |
Safer Medication Use for Children with Chronic Illness | University of California, San Francisco-Stanford University | 2017 | CERSI | Complete |
*Chart information presented from 2017